Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2008

01-10-2008 | Research Article

The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul

Authors: Hale Zerrin Toklu, Meral Keyer Uysal

Published in: International Journal of Clinical Pharmacy | Issue 5/2008

Login to get access

Abstract

Objective We investigated the knowledge and attitudes of community pharmacists towards pharmacovigilance and adverse drug reactions (ADRs) in Kadıköy district of Istanbul (Turkey). Setting The community pharmacies in Kadikoy. Kadikoy is one of the biggest districts of Istanbul and has the largest number of pharmacies. Kadikoy district was divided into two regions, the central and the peripheral. Method Between December 2005 and June 2006 we conducted a survey about the knowledge and attitude of community pharmacists (n = 219) using a face-to-face questionnaire. The questionnaire consisted of questions about the sociodemographic characteristics of the pharmacists, their knowledge of pharmacovigilance and their attitudes towards ADR reporting. Main outcomes measured The knowledge of pharmacovigilance practice, ADR reporting compliance rates, reasons for not reporting ADR and perceptions of the Turkish community pharmacists on pharmacovigilance practice were evaluated. Results Although all 411 pharmacies in the Kadikoy district were visited, only 53% of the community pharmacists (n = 219) consented to participate in the study. Of those that did respond, only 17.2% of the pharmacists had any knowledge about ‘pharmacovigilance’. Sixty-five percent of the pharmacists stated that patients reported an ADR to them during the previous 12 months, and 21% of pharmacists reported to the concerned organizations. Our survey showed that only 7% actually reported an ADR to the national pharmacovigilance center. On the other hand, 89% of the pharmacists believed that the role of the pharmacist in ADR reporting was essential. Conclusion The results show that Turkish community pharmacists have poor knowledge about pharmacovigilance. There is an urgent need for educational programs to train them about pharmacovigilance and ADR reporting.
Literature
1.
go back to reference Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18(3):275–80.PubMedCrossRef Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18(3):275–80.PubMedCrossRef
2.
go back to reference WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002. ISBN 92-4-159015-7. WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002. ISBN 92-4-159015-7.
3.
go back to reference Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335(7618):462.PubMedCrossRef Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335(7618):462.PubMedCrossRef
6.
go back to reference Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed
7.
go back to reference Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed
8.
go back to reference Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety. 2000;23(2):165–72.PubMedCrossRef Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety. 2000;23(2):165–72.PubMedCrossRef
9.
go back to reference Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Safety. 2006;29(4):331–40.PubMedCrossRef Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Safety. 2006;29(4):331–40.PubMedCrossRef
10.
go back to reference Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Safety. 2007;16(4):429–34.CrossRef Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Safety. 2007;16(4):429–34.CrossRef
11.
go back to reference Beşeri Tıbbi Ürünlerin Güvenliğinin İzlenmesi ve Değerlendirilmesi Hakkında Yönetmelik (22 Mart 2005 tarihli ve 25763 sayılı Resmi Gazete, yürürlüğe giriş tarihi: 30/06/2005) [Guide for the monitorization and evaluation of the medicinal products. Published in the official gazette in 30th March 2005 to become valid by 30th June 2005]. http://rega.basbakanlik.gov.tr/. Accessed Oct 26th, 2007. Beşeri Tıbbi Ürünlerin Güvenliğinin İzlenmesi ve Değerlendirilmesi Hakkında Yönetmelik (22 Mart 2005 tarihli ve 25763 sayılı Resmi Gazete, yürürlüğe giriş tarihi: 30/06/2005) [Guide for the monitorization and evaluation of the medicinal products. Published in the official gazette in 30th March 2005 to become valid by 30th June 2005]. http://​rega.​basbakanlik.​gov.​tr/​. Accessed Oct 26th, 2007.
12.
go back to reference Ozcelikay G, Tekiner H. Turkiye’de Eczacılık Insan Gucunun Degerlendirilmesi ve Eczane Dagilimlari. [The distribution of the pharmacies in Turkey and evaluation of Pharmacist resources in Turkey]. Turkish Pharmacist Association Publications, Ankara, Turkey; 2007. ISBN 978-975-01139-4-9. Ozcelikay G, Tekiner H. Turkiye’de Eczacılık Insan Gucunun Degerlendirilmesi ve Eczane Dagilimlari. [The distribution of the pharmacies in Turkey and evaluation of Pharmacist resources in Turkey]. Turkish Pharmacist Association Publications, Ankara, Turkey; 2007. ISBN 978-975-01139-4-9.
13.
go back to reference Onder Ozhan. Eczacı Profili: 1998–2007 Son On Yıla Bir Bakış [The profile of the community pharmacists: 1998–2007 An overview of the last ten years]. Turkish Pharmacist Association Publications, Ankara, Turkey; Research Series 2007. Onder Ozhan. Eczacı Profili: 1998–2007 Son On Yıla Bir Bakış [The profile of the community pharmacists: 1998–2007 An overview of the last ten years]. Turkish Pharmacist Association Publications, Ankara, Turkey; Research Series 2007.
14.
go back to reference Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385–96.PubMedCrossRef Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385–96.PubMedCrossRef
16.
go back to reference Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Granas AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Safety. 2007;16(9):999–1005.CrossRef Gedde-Dahl A, Harg P, Stenberg-Nilsen H, Buajordet M, Granas AG, Horn AM. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Safety. 2007;16(9):999–1005.CrossRef
17.
go back to reference van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Safety. 2004;13(7):457–64.CrossRef van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Safety. 2004;13(7):457–64.CrossRef
Metadata
Title
The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul
Authors
Hale Zerrin Toklu
Meral Keyer Uysal
Publication date
01-10-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9209-4

Other articles of this Issue 5/2008

International Journal of Clinical Pharmacy 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.